Philip J. Barr

Philip J. Barr's AcademicInfluence.com Rankings

Philip J. Barr

Biology

#11198

World Rank

#14577

Historical Rank

Virology

#268

World Rank

#275

Historical Rank

Genetics

#1198

World Rank

#1299

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Philip J. Barr Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philip J. Barr's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic organization and diversity of the hepatitis C virus. (1991) (1753)
Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. (1994) (1174)
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression (1988) (956)
Mammalian subtilisins: The long-sought dibasic processing endoproteases (1991) (684)
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). (1985) (643)
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak (1995) (540)
Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. (1985) (475)
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. (1984) (412)
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. (1979) (400)
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs (1983) (396)
Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro- beta-NGF in vivo (1990) (314)
The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. (1987) (303)
Redesigning trypsin: alteration of substrate specificity. (1985) (299)
Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. (1990) (253)
Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. (1988) (253)
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. (1986) (249)
Identification of a second human subtilisin-like protease gene in the fes/fps region of chromosome 15. (1991) (242)
Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. (1990) (235)
Apoptosis and Its Role in Human Disease (1994) (228)
Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals (1991) (219)
Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. (1991) (208)
A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria (1996) (202)
Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. (1998) (200)
Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. (1992) (185)
Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. (1986) (180)
Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). (1988) (175)
NUCLEIC ACID RELATED COMPOUNDS. 39. EFFICIENT CONVERSION OF 5-IODO TO 5-ALKYNYL AND DERIVED 5-SUBSTITUTED URACIL BASES AND NUCLEOSIDES (1983) (170)
Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsin (1984) (168)
A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. (1992) (165)
Molecular Cloning and Structural Characterization of the Arg-gingipain Proteinase of Porphyromonas gingivalis (1995) (146)
The Tumor Suppressor Maspin Does Not Undergo the Stressed to Relaxed Transition or Inhibit Trypsin-like Serine Proteases. (1995) (140)
The cDNA and derived amino acid sequence for human osteopontin. (1989) (139)
Fas/APO-1 gene transfer for human malignant glioma. (1995) (132)
Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3 (1992) (130)
Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum (1994) (129)
Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth. (1981) (128)
Synthetic peptide vaccine confers protection against murine malaria (1987) (119)
Molecular Cloning and Characterization of Porphyromonas gingivalis Lysine-specific Gingipain (1997) (113)
Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. (1987) (111)
The ompA signal peptide directed secretion of Staphylococcal nuclease A by Escherichia coli. (1985) (107)
7-Deaza-2'-deoxyguanosine-5'-triphosphate: enhanced resolution in M13 dideoxy sequencing (1986) (107)
Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor (1988) (104)
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. (1986) (103)
Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. (1985) (101)
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T). (1992) (99)
Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. (1989) (99)
Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. (1992) (98)
Nucleic acid related compounds. 31. Smooth and efficient palladium-copper catalyzed coupling of terminal alkynes with 5-iodouracil nucleosides (1981) (98)
cDNA and gene structure for a human subtilisin-like protease with cleavage specificity for paired basic amino acid residues. (1991) (97)
Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast. (1983) (95)
Sequences homologous to the variant antigen mRNA spliced leader are located in tandem repeats and variable orphons in Trypanosoma brucei (1983) (94)
Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. (1990) (94)
Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum (1991) (84)
Cloning of the proteinase that facilitates infection by schistosome parasites. (1988) (83)
Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations. (1990) (82)
Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. (1989) (80)
Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosides. (1983) (79)
Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas. (1985) (72)
Yeast KEX2 protease has the properties of a human proalbumin converting enzyme. (1987) (70)
Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae. (1988) (66)
Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant (1993) (66)
Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals (1986) (65)
Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice. (1992) (62)
Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. (1987) (60)
Expression of Active Human Immunodeficiency Virus Reverse Transcriptase in Saccharomyces Cerevisiae (1987) (59)
Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys. (1989) (59)
Yeast genetic engineering. (1989) (58)
Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine (1987) (58)
Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei (1988) (58)
PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE. (1993) (56)
Molecular cloning of a functional bovine interleukin 2 cDNA. (1986) (56)
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. (1992) (55)
Modulation of human natural killer cell activity by recombinant human interleukin 2. (1985) (54)
Inhaled Recombinant Alpha 1-Antitrypsin Ameliorates Cigarette Smoke-Induced Emphysema in the Mouse (2006) (52)
High-Level Expression and In Vivo Processing of Chimeric Ubiquitin Fusion Proteins in Saccharomyces Cerevisiae (1989) (52)
Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A (1989) (51)
Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. (1991) (51)
Nucleic acid related compounds. 38. Smooth and high-yield iodination and chlorination at C-5 of uracil bases and p-toluyl-protected nucleosides (1982) (50)
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. (1991) (48)
Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity (1993) (47)
Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. (1994) (47)
Malaria transmission-blocking vaccines. (1992) (45)
The cDNA and derived amino acid sequences of human and bovine bone Gla protein. (1988) (44)
Sequences homologous to variant antigen mRNA spliced leader in Trypanosomatidae which do not undergo antigenic variation (1984) (44)
Human pepsinogen C (progastricsin). Isolation of cDNA clones, localization to chromosome 6, and sequence homology with pepsinogen A. (1989) (43)
Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice (1979) (42)
An Inhaled Matrix Metalloprotease Inhibitor Prevents Cigarette Smoke-Induced Emphysema in the Mouse (2005) (39)
RECOMBINANT ALPHA-1-ANTITRYPSIN PITTSBURGH ATTENUATES EXPERIMENTAL GRAM-NEGATIVE SEPTICEMIA (1988) (39)
In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. (1992) (38)
Identification and cloning of a locus of serine repeat antigen (sera)-related genes from Plasmodium vivax. (1996) (35)
Inhibition of thymidylate synthetase by 5-alkynyl-2'-deoxyuridylates. (1981) (33)
Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys). (1990) (33)
Role of thymidine kinase in the inhibitory activity of 5-substituted-2'-deoxyuridines on the growth of human and murine tumor cell lines. (1982) (32)
Pharmacokinetics of E-5-(2-Bromovinyl)-2′-Deoxyuridine in Mice (1979) (30)
Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β (1991) (29)
Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeast. (1990) (29)
Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21.1-pter. (1989) (28)
Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. (1991) (28)
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro. (1990) (28)
Interactions with tRNALys induce important structural changes in human immunodeficiency virus reverse transcriptase (1990) (28)
Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents. (1991) (28)
Genomic structure and domain organisation of the human Bak gene. (1998) (28)
Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein (1988) (27)
The synthesis of nucleosides derived from 5-ethynyluracil and 5-ethynylcytosine (1979) (27)
Primary structure of the putative human oncogene, pim-1. (1990) (27)
Interaction of tRNALys with the p66/p66 form of HIV-1 reverse transcriptase stimulates DNA polymerase and ribonuclease H activities. (1992) (27)
Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus (1993) (26)
Functional implications of the modeled structure of maspin. (1996) (25)
The synthesis and properties of some antiviral nucleosides (1978) (25)
COMPARATIVE STUDY OF THE POTENCY AND SELECTIVITY OF ANTI-HERPES COMPOUNDS (1979) (22)
COMPARATIVE STUDY OF THE POTENCY AND SELECTIVITY OF ANTI-HERPES COMPOUNDS (1979) (22)
N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae (1989) (22)
Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. (1993) (22)
New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase. (1992) (22)
Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein (1989) (21)
Functional analysis of primers and templates in the synthesis of DNA catalyzed by human immunodeficiency virus type 1 reverse transcriptase. (1992) (21)
Recombinant DNA-derived forms of human alpha 1-proteinase inhibitor. Studies on the alanine 358 and cysteine 358 substituted mutants. (1986) (20)
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25. (1992) (20)
Simian retrovirus-D serotype 1 (SRV-1) envelope glycoproteins gp70 and gp20: expression in yeast cells and identification of specific antibodies in sera from monkeys that recovered from SRV-1 infection (1988) (20)
Characterization of a recombinant Onchocerca volvulus antigen (Ov33) produced in yeast. (1997) (20)
Reaction of 5-ethynyl-2'-deoxyuridylate with thiols and thymidylate synthetase. (1983) (20)
Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. (1990) (19)
Thymidylate synthetase-catalyzed conversions of E-5-(2-bromovinyl)-2'-deoxyuridylate. (1983) (18)
Selection of COS cell mutants defective in the biosynthesis of heparan sulfate proteoglycan. (1992) (17)
Stabilization and activation of recombinant human immunodeficiency virus-1 reverse transcriptase-P66. (1990) (17)
Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoites. (1997) (17)
Synthesis of some 5-halogenovinyl derivatives of uracil and their conversion into 2′-deoxyribonucleosides (1981) (17)
The Molecular Biology of Heparan Sulfate Fibroblast Growth Factor Receptors a (1991) (17)
Biochemical characterization of the p51 sub‐unit of human immunodeficiency virus reverse transcriptase in homo‐ and heterodimeric recombinant forms of the enzyme (1992) (16)
Incorporation of 5-substituted uracil derivatives into nucleic acids. Part IV. The synthesis of 5-ethynyluracil. (1976) (16)
The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template. (1992) (16)
Alpha 1‐Antitrypsin and Ilomastat Inhibit Inflammatory Proteases Present in Human Middle Ear Effusions (2003) (15)
A cell-based assay for evaluating the interaction of heparin-like molecules and basic fibroblast growth factor. (1992) (14)
Bovine interleukin 2: regulatory mechanisms. (1987) (14)
Identification of a lichen depside polyketide synthase gene by heterologous expression in Saccharomyces cerevisiae (2021) (13)
Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. (1990) (13)
Azomycin riboside, a sugar homologue of misonidazole with favorable radiosensitizing properties. (1982) (11)
Immunogenic properties of the M. leprae recombinant 18-kDa antigen purified from Saccharomyces cerevisiae; enhancement of delayed-type hypersensitivity after gamma-irradiation. (1995) (11)
Development and maintenance of bovine cytotoxic lymphocytes with recombinant human interleukin-2. (1986) (10)
The synthesis and crystal structure of 5-acetyl-2'-deoxyuridine (1980) (10)
Protease inhibitors α1‐antitrypsin and ilomastat are not ototoxic in the chinchilla (2003) (9)
The cDNA and derived amino acid sequences for human and bovine matrix Gla protein. (1988) (9)
Antiviral nucleic acid derivatives. III. Crystal structure of 5-ethynyl-2'-deoxyuridine (1978) (9)
Recombinant subunit vaccines from yeast. (1989) (9)
Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase. (1993) (8)
Characterization of antithrombins produced by active site mutagenesis of human alpha 1-antitrypsin expressed in yeast. (1989) (8)
Biologic activities of recombinant human interleukin 2 on murine lymphocytes. (1985) (8)
Induction of sporozoite‐specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein (1987) (7)
Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems. (1992) (7)
Inflammatory Proteases in Chronic Otitis Externa (2005) (6)
Relative Potencies ofDifferent Anti-Herpes Agents inthe Topical Treatment ofCutaneous Herpes Simplex Virus Infection ofAthymic NudeMice (1979) (6)
Cannabichromene Racemization and Absolute Stereochemistry Based on a Cannabicyclol Analog. (2021) (5)
NUCLEIC ACID RELATED COMPOUNDS. 38. SMOOTH AND HIGH-YIELD IODINATION AND CHLORINATION AT C-5 OF URACIL BASES AND P-TOLYL-PROTECTED NUCLEOSIDES (1982) (5)
Interactions with tRNA(Lys) induce important structural changes in human immunodeficiency virus reverse transcriptase. (1990) (4)
Onchocerca volvulus: identification and characterization of an immunogenic eggshell protein (Oveg1). (1995) (4)
NUCLEIC ACID RELATED COMPOUNDS. 40. SYNTHESIS AND BIOLOGICAL ACTIVITIES OF 5-ALKYNYLURACIL NUCLEOSIDES (1983) (4)
Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media. (2004) (3)
Ubiquitin Fusion Approach to Heterologous Gene Expression in Yeast: High-Level Production of Amino-Terminal Authentic Proteins (1991) (3)
Nucleotide sequence of human mitochondrial cytochrome c oxidase II cDNA. (1989) (2)
Expression of the 18kDa protein of Mycobacterium leprae in Saccharomyces cerevisiae (1994) (2)
Soy (Glycine max)-derived phospholipids exhibit potent anti-apoptotic activity (1998) (2)
INHIBITION OF THYMIDYLATE SYNTHETASE BY 5-ALKYNYL-2′-DEOXYURIDYLATES (1982) (2)
Human immunodeficiency virus type-1 reverse transcriptase copies very short templates: kinetic and crosslinking analysis. (1993) (2)
SYNTHESIS OF SOME 5-HALOVINYL DERIVATIVES OF URACIL AND THEIR CONVERSION INTO 2′-DEOXYRIBONUCLEOSIDES (1981) (1)
Modulation of human natural killer cell activity by recombinant human interleukin 2. (1985) (1)
Pyridoxal-5′-Phosphate Inhibits the Polymerase Activity of a Recombinant RNase H-Deficient Mutant of HIV-1 Reverse Transcriptase (1992) (1)
Nucleic Acids Research (2016) (1)
The synthesis of some tritiated 5‐substituted uracil derivatives (1979) (1)
Isolation and Properties of Recombinant DNA Produced Variants of Human al-Proteinase Inhibitor * (2001) (1)
Procede de preparation de fragments de retrovirus du groupe du sida (1985) (0)
Recombinant Polypeptide from the Endonuclease Regiorn of the (0)
P059: Inhibition of Proteases with Alpha 1-Antitrypsin and Ilomastat in Human Otitis Media (2003) (0)
Pace expression into host cells and methods of use thereof. (1991) (0)
Protease inhibitor therapeutics for respiratory disease (2004) (0)
Proteines recombinantes de virus associes au syndrome d'adenopathie et/ou au syndrome d'immuno-deficience acquise (1985) (0)
Alpha-1-Antitrypsin Single Dose Adjuvant Therapy for Acute Otitis Media (2004) (0)
Production of the gasoline additive 3-methylanisole via fermentation of cellulosic sugars. (CRADA Final Report) (2017) (0)
Hybrid DNA in synthesis of homogeniserad vaextfaktor of insulintyp. (1984) (0)
protective immunity . falciparum : adjuvant effects on induction of by a recombinant SERA protein of Plasmodium Protective immunity induced in Aotus monkeys (2003) (0)
New chemical compounds, processes for their preparation and their use as medicine with antiviral effective (1979) (0)
Proteins that modulate apoptosis, codante DNA for these proteins, and its method of use. (1994) (0)
Pyridoxal-5'-phosphate inhibits the polymerase activity of a recombinant RNAase H-deficient mutant of HIV-1 reverse transcriptase. (1992) (0)
Composition for the treatment of ichthyosis using antitrypsin (2003) (0)
Composition for the treatment of ictiosis using antitripsin. (2003) (0)
A process for preparing a human insulin-like growth factor in the hybrid DNA synthesis (1984) (0)
Ted-2'-deoxyuridines on the growth of human and murine tumor cell lines. (1982) (0)
Gene system encoding human insulin-like growth factor (1994) (0)
Composition which uses apoptosis prevented this method of cleaning composition thereof and (1994) (0)
Recombinant cx1-Antitrypsin Pittsburgh Attenuates Experimental Grar-Negative Septicem ia (2007) (0)
Multifunctional protease inhibitors and their use for the treatment of diseases (2001) (0)
Comparative Utility of Mineralized Collagen as an Osteoinductive Material (2017) (0)
Role of Tyrosine Kinase and Membrane-Spanning Domains in Signal Transduction by the Platelet-Derived Growth Factor Receptor (1990) (0)
Recombinant viral proteins accompanied by lymphadenopathischem syndrome and / or "Acquired Immune Deficiency Syndrome" (AIDS) (1985) (0)
Protease inhibitors of the alpha-1-antitrypsin type modified aktiever point and their preparation. (1985) (0)
Compositions of alpha-1 antitrypsin and methods of treatment using such compositions. (2004) (0)
Inflammatory Proteases in Chronic Otitis Media Externa (2004) (0)
Recombinant SERA Protein of Plasmodium falciparum: Adjuvant Effects (2003) (0)
Recombinant proteins with lymphadenopathy syndrome and / or acquired Immunschw {chesyndrom associated viruses. (1985) (0)
Recombinant proteins associated with lymphadenopathy syndrome and / or acquired immune deficiency syndrome virus (1985) (0)
Longevity by Design (1994) (0)
THE SYNTHESIS AND CRYSTAL STRUCTURE OF 5-ACETYL-2′-DEOXYURIDINE (1980) (0)
Hybrid-dns-synthesis of mature insulinaehnlichen growth factors. (1984) (0)
Molecular cloning and sequence identification of human group ii pepsinogens (1986) (0)
Hybrid dns-synthesis of mature wachstumshormonausloesendem factor. (1984) (0)
Recombinant production systems for prenylated polyketides of the cannabinoid family (2018) (0)
Mammalian cell technology: Secretion on demand (1995) (0)
Recombinant production systems for decarboxylated aromatic molecules (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Philip J. Barr?

Philip J. Barr is affiliated with the following schools:

University of California, San Francisco

Philip J. Barr's Academic­Influence.com Rankings

Why Is Philip J. Barr Influential?

Philip J. Barr's Published Works

Published Works

What Schools Are Affiliated With Philip J. Barr?

Philip J. Barr's AcademicInfluence.com Rankings